Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
How Tesamorelin Is Studied in GH-Axis Research Tesamorelins mechanism is studied indirectly: rather than acting on fat cells or metabolic receptors directly, it stimulates the pituitary gland to increase natural growth hormone output, which in turn influences downstream fat metabolism through the bodys own GH/IGF-1 signaling axis
The appropriate syringe capacity is used for precise dosage delivery
Furthermore, most GIPR agonists have been shown to reduce food intake in high-fat diet-induced obese mice [32]
The timeline comparison is illuminating
As a once-weekly subcutaneous injectable medication typically used for the long-term management of obesity, it mimics the action of the GLP-1 hormone, which is naturally released after eating
GLP-1Rs is present in many tissues, suggesting that their widespread physiological functions beyond glycemic control could potentially include, for example, neuroprotective, anti-inflammatory, and cardioprotective activity [13]
US$ 23.40
US$ 27.37
US$ 28.57
